$SNBH
SENTIENT BRANDS HOLDINGS INC.

2022 Q4 Form 10-Q Financial Statement

#000173112222002027 Filed on November 21, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $10.00
YoY Change -98.21%
Cost Of Revenue -$4.210K
YoY Change
Gross Profit $4.220K
YoY Change 653.57%
Gross Profit Margin 42200.0%
Selling, General & Admin $42.54K $42.26K $151.1K
YoY Change -74.95% -72.04%
% of Gross Profit 1008.06%
Research & Development $270.00
YoY Change
% of Gross Profit
Depreciation & Amortization $970.00 -$1.670K $1.260K
YoY Change -22.4% -232.54%
% of Gross Profit 22.99%
Operating Expenses $42.53K $85.33K $151.4K
YoY Change -63.76% -43.64%
Operating Profit -$38.31K -$85.33K -$151.4K
YoY Change -67.2% -43.64%
Interest Expense -$98.76K $43.07K -$19.58K
YoY Change 48.4% -319.95%
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change -100.0%
Pretax Income -$137.1K -$85.33K -$174.9K
YoY Change -466.01% -51.22%
Income Tax
% Of Pretax Income
Net Earnings -$137.1K -$85.33K -$174.9K
YoY Change -466.01% -51.22%
Net Earnings / Revenue -1370700.0%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 -$1.636K -$3.385K
COMMON SHARES
Basic Shares Outstanding 52.42M shares 51.92M shares
Diluted Shares Outstanding 52.15M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.050K $1.310K $32.85K
YoY Change -98.91% -96.01%
Cash & Equivalents $1.048K $1.307K $32.85K
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change
Inventory $238.0K $238.0K $258.8K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $239.1K $239.3K $291.6K
YoY Change -32.65% -17.94%
LONG-TERM ASSETS
Property, Plant & Equipment $27.62K $28.59K $33.04K
YoY Change -13.1% -13.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $27.62K $28.59K $33.04K
YoY Change -13.1% -13.47%
TOTAL ASSETS
Total Short-Term Assets $239.1K $239.3K $291.6K
Total Long-Term Assets $27.62K $28.59K $33.04K
Total Assets $266.7K $267.9K $324.7K
YoY Change -31.05% -17.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $540.2K $473.6K $271.2K
YoY Change 189.62% 74.61%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $1.369M $1.300M $1.026M
YoY Change 26.78%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.910M $1.774M $1.297M
YoY Change 44.54% 36.79%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.910M $1.774M $1.297M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.910M $1.774M $1.297M
YoY Change 44.54% 36.79%
SHAREHOLDERS EQUITY
Retained Earnings -$3.056M -$2.919M
YoY Change 31.66%
Common Stock $52.42K $52.42K
YoY Change 0.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.643M -$1.506M -$972.1K
YoY Change
Total Liabilities & Shareholders Equity $266.7K $267.9K $324.7K
YoY Change -31.05% -17.48%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$137.1K -$85.33K -$174.9K
YoY Change -466.01% -51.22%
Depreciation, Depletion And Amortization $970.00 -$1.670K $1.260K
YoY Change -22.4% -232.54%
Cash From Operating Activities -$24.91K -$14.06K -$110.1K
YoY Change -91.05% -87.23%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 24.66K 15.14K 134.0K
YoY Change -92.78% -88.7%
NET CHANGE
Cash From Operating Activities -24.91K -14.06K -110.1K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 24.66K 15.14K 134.0K
Net Change In Cash -250.0 1.080K 23.88K
YoY Change -100.39% -95.48%
FREE CASH FLOW
Cash From Operating Activities -$24.91K -$14.06K -$110.1K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$14.06K -$110.1K
YoY Change -87.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 snbh Canceled Shares
CanceledShares
usd
snbh Stock Issued For Services Rendered
StockIssuedForServicesRendered
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001358633
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 us-gaap Gross Profit
GrossProfit
usd
CY2021Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
usd
CY2022Q3 snbh Office Rent
OfficeRent
usd
snbh Office Rent
OfficeRent
usd
CY2022Q3 us-gaap Management Fee Expense
ManagementFeeExpense
usd
CY2022Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
usd
CY2021Q4 us-gaap Assets
Assets
386762 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
473587 usd
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-34861
dei Entity Registrant Name
EntityRegistrantName
SENTIENT BRANDS HOLDINGS INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-3765910
dei Entity Address Address Line1
EntityAddressAddressLine1
590 Madison Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
21st Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
dei City Area Code
CityAreaCode
646
dei Local Phone Number
LocalPhoneNumber
202-2897
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
52420387 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1307 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96198 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
238016 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
258781 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
239323 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
354979 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28590 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31783 usd
CY2022Q3 us-gaap Assets
Assets
267913 usd
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
876363 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1773822 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1321183 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
186528 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
430871 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Legal Fees
LegalFees
32816 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
258292 usd
CY2022Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
869364 usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52420387 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52420387 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51920387 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51920387 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
52421 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
51921 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1359249 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1333567 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2918579 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2320909 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-1505909 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-934421 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
267913 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
386762 usd
us-gaap Revenues
Revenues
553 usd
us-gaap Revenues
Revenues
125 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4323 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
23 usd
us-gaap Gross Profit
GrossProfit
-3770 usd
us-gaap Gross Profit
GrossProfit
102 usd
CY2022Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
4462 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
43075 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
12800 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4984 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25264 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24871 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35748 usd
CY2021Q3 us-gaap Legal Fees
LegalFees
104499 usd
us-gaap Legal Fees
LegalFees
343855 usd
us-gaap Legal Fees
LegalFees
250376 usd
CY2021Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
268 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
3153 usd
CY2021Q3 snbh Office Rent
OfficeRent
366 usd
snbh Office Rent
OfficeRent
824 usd
CY2021Q3 us-gaap Management Fee Expense
ManagementFeeExpense
21000 usd
us-gaap Management Fee Expense
ManagementFeeExpense
69000 usd
us-gaap Management Fee Expense
ManagementFeeExpense
63000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
43066 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
19575 usd
us-gaap Interest Expense
InterestExpense
113098 usd
us-gaap Interest Expense
InterestExpense
38841 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
85328 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
170972 usd
us-gaap Operating Expenses
OperatingExpenses
593899 usd
us-gaap Operating Expenses
OperatingExpenses
404742 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-85328 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-170972 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-597669 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-404640 usd
CY2021Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3949 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6579 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6750 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-85328 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-174921 usd
us-gaap Net Income Loss
NetIncomeLoss
-597669 usd
us-gaap Net Income Loss
NetIncomeLoss
-404469 usd
CY2022Q3 snbh Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.002
CY2021Q3 snbh Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.003
snbh Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.011
snbh Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.008
CY2022Q3 snbh Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
52149735 shares
CY2021Q3 snbh Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
51670687 shares
snbh Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
51997676 shares
snbh Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
51669387 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-934421 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-217831 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1152252 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-294510 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1446762 usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
26182 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-85328 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-1505909 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-568749 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-86070 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-654819 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1100 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-143479 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-797198 usd
us-gaap Depreciation
Depreciation
3765 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6579 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-174921 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-972119 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
597670 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
404469 usd
us-gaap Depreciation
Depreciation
3193 usd
snbh Stock Issued For Services Rendered
StockIssuedForServicesRendered
26182 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-20765 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
258781 usd
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
154893 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
259716 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
25116 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-287814 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-472898 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
306199 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
192924 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
130404 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1100 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
192924 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
437703 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-94891 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-35195 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96198 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
68047 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1307 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32852 usd
us-gaap Interest Paid Net
InterestPaidNet
21052 usd
CY2020Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
7 for 1
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
us-gaap Basis Of Accounting
BasisOfAccounting
<p id="xdx_808_eus-gaap--BasisOfAccounting_zxLKYZJBgkM" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 – <span id="xdx_82D_zlTPijOS3Mw8">BASIS OF PRESENTATION AND GOING CONCERN</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Basis of Presentation</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These interim consolidated financial statements of the Company and its subsidiaries are unaudited. In the opinion of management, all adjustments (consisting of normal recurring accruals) and disclosures necessary for a fair presentation of these interim condensed consolidated financial statements have been included. The results reported in the unaudited condensed consolidated financial statements for any interim periods are not necessarily indicative of the results that may be reported for the entire year. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission and do not include all information and footnotes necessary for a complete presentation of financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”). The Company’s unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain information and footnote disclosures normally included in the annual consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2021 filed with the Securities and Exchange Commission on April 29, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Going concern</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company currently has limited operations. These unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates, among other things, the realization of assets and the satisfaction of liabilities in the normal course of business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As reflected in the accompanying unaudited consolidated financial statements, the Company had an accumulated deficit of $<span id="xdx_90D_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20220930_zBbhujz0t319" title="Accumulated deficit">2,918,579</span> at September 30, 2022 and had a net loss and net cash flow used in operating activities of $<span id="xdx_903_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20220101__20220930_pp0p0" title="Net loss">597,670</span> and $<span id="xdx_909_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20220101__20220930_z52mEjOvYEBd" title="Net cash flow used in operating activities">287,814</span>, respectively for the nine months ended September 30, 2022, respectively. The Company has a limited operating history, and its continued growth is dependent upon the continuation of selling its products; hence generating revenues and obtaining additional financing to fund future obligations and pay liabilities arising from normal business operations. These matters raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to raise additional capital, implement its business plan, and generate significant revenues. There are no assurances that the Company will be successful in its efforts to generate significant revenues, maintain sufficient cash balance or report profitable operations or to continue as a going concern. The Company plans on raising capital through the sale of equity or debt instruments to implement its business plan. However, there is no assurance these plans will be realized and that any additional financings will be available to the Company on satisfactory terms and conditions, if any.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2918579 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
597670 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-287814 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_zttgZAPBa1Ol" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_864_zOP6sgnNbDkb">Uses of estimates in the preparation of financial statements</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses during each reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022Q3 us-gaap Inventory Net
InventoryNet
238016 usd
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
7 for 1
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares

Files In Submission

Name View Source Status
0001731122-22-002027-index-headers.html Edgar Link pending
0001731122-22-002027-index.html Edgar Link pending
0001731122-22-002027.txt Edgar Link pending
0001731122-22-002027-xbrl.zip Edgar Link pending
e4249_10q.htm Edgar Link pending
e4249_ex31-1.htm Edgar Link pending
e4249_ex31-2.htm Edgar Link pending
e4249_ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
e4249_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
snbh-20220930.xsd Edgar Link pending
snbh-20220930_cal.xml Edgar Link unprocessable
snbh-20220930_def.xml Edgar Link unprocessable
snbh-20220930_pre.xml Edgar Link unprocessable
snbh-20220930_lab.xml Edgar Link unprocessable